Given that NE is closely related to the regulation of numerous immune cells in the tumor immune microenvironment, we conducted an analysis of relevant indicators for the clinical evaluation of immunotherapy results with its degrading enzyme MAOA. The gene discussed is MAOA; the disease is neoplasm.